Protease Activity in a Hapten-Induced Model of Ulcerative Colitis in Rats

被引:0
|
作者
James V. Hawkins
Eva L. Emmel
Jennifer J. Feuer
Mark A. Nedelman
Catherine J. Harvey
Hilton J. Klein
Harry Rozmiarek
Ann R. Kennedy
Gary R. Lichtenstein
Paul C. Billings
机构
来源
关键词
PROTEASE ACTIVITY; ULCERATIVE COLITIS;
D O I
暂无
中图分类号
学科分类号
摘要
Inflammatory bowel disease (IBD) is a painfuland debilitating condition affecting the mucosal liningof the colon and other areas of the gastrointestinaltract. IBD generally falls into two major categories: ulcerative colitis (UC) and Crohn's disease. Wehave utilized dinitrobenzenesulfonic acid (DNBS) toinduce experimental UC in rats. Histopathologic analysisindicates that DNBS induces a condition in animals similar to human UC. Biochemical resultsrevealed 6- to 10-fold elevated levels of serineprotease activity in colon tissue from animals with UCas compared with matched controls. We also observedelevated levels of protease activity in tissue samplesobtained from human patients with UC. Hence, our resultsdemonstrate that protease activity is increased inrodent and human UC. These proteases may play a significant role in destruction of colonictissue in IBD. Protease inhibitors that target serineproteases may be useful pharmacological agents to limittissue destruction in IBD.
引用
收藏
页码:1969 / 1980
页数:11
相关论文
共 50 条
  • [31] Role of tumor necrosis factor-alpha (TNF) in hapten-induced colitis.
    Videla, S
    Vilaseca, S
    Gonzalez, G
    Salas, A
    GarciaLafuente, A
    Antolin, M
    Guarner, F
    Malagelada, JR
    GASTROENTEROLOGY, 1996, 110 (04) : A1039 - A1039
  • [32] Vidofludimus Inhibits Colonic Interleukin-17 and Improves Hapten-Induced Colitis in Rats by a Unique Dual Mode of Action
    Fitzpatrick, Leo R.
    Small, Jeffrey S.
    Doblhofer, Robert
    Ammendola, Aldo
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (03): : 850 - 860
  • [33] Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis
    Ribbons, KA
    Thompson, JH
    Liu, XP
    Pennline, K
    Clark, DA
    Miller, MJS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) : 245 - 254
  • [34] Oral administration of a food coloring agent, tartrazine, enhances the development of hapten-induced colitis and delays its healing in rats.
    Shoda, R
    Uchida, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1370 - A1370
  • [35] Different susceptibilities of spontaneous rhythmicity and myogenic contractility to intestinal muscularis inflammation in the hapten-induced colitis
    Kiyosue, M.
    Fujisawa, M.
    Kinoshita, K.
    Hori, M.
    Ozaki, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2006, 18 (11): : 1019 - 1030
  • [36] A MODEL FOR THE HAPTEN-INDUCED ENHANCEMENT OF MONOCLONAL-ANTIBODY BINDING IN ELISA
    HALL, TJ
    KANG, CY
    MOLECULAR IMMUNOLOGY, 1988, 25 (01) : 85 - 86
  • [37] Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis
    Armstrong, AM
    Foulkes, R
    Jennings, G
    Gannon, C
    Kirk, SJ
    Gardiner, KR
    BRITISH JOURNAL OF SURGERY, 2001, 88 (02) : 235 - 240
  • [38] Neutralization of vascular endothelial growth factor prolongs intestinal inflammation in hapten-induced colitis.
    Mitsuyama, K
    Nishiyama, T
    Tateishi, H
    Saiki, T
    Ide, M
    Shirachi, A
    Tomiyasu, N
    Toyonaga, A
    Matsuo, K
    Tanikawa, K
    GASTROENTEROLOGY, 1998, 114 (04) : A399 - A399
  • [39] The protective action of radix Astragalus membranaceus against hapten-induced colitis through modulation of cytokines
    Ko, Joshua Ka-Shun
    Chik, Cecilia Wai-Shan
    CYTOKINE, 2009, 47 (02) : 85 - 90
  • [40] The murine bronchopulmonary microcirculation in hapten-induced inflammation
    Ravnic, Dino J.
    Konerding, Moritz A.
    Pratt, Juan P.
    Wolloscheck, Tanja
    Huss, Harold T.
    Mentzer, Steven J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (01): : 97 - 103